AKEBIA THERAPEUTICS INC (AKBA) Stock Cash Flow
NASDAQ:AKBA - Nasdaq - US00972D1054 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -45.31M | -69.41M | -51.92M | -92.56M | -282.84M | |||
| Depreciation Amortization | 28.44M | 37.50M | 37.63M | 37.69M | 37.97M | |||
| Change In Working Capital | -54.26M | -39.68M | -20.73M | -10.99M | -108.42M | |||
| Interest Paid | N/A | 5.04M | 6.06M | 6.76M | 9.63M | |||
| Other non cash items | 36.31M | 30.92M | 11.64M | -7.30M | 100.32M | |||
| OPERATING CASH FLOW | -34.81M | -40.66M | -23.38M | -73.15M | -252.97M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -33.00K | 0.00 | -110.00K | -60.00K | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 40.00M | |||
| INVESTING CASH FLOW | N/A | -33.00K | 0.00 | -110.00K | 39.94M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 17.16M | 7.90M | -32.00M | -33.00M | 0.00 | |||
| Stock Issued/Repurchased | 89.55M | 43.03M | 6.79M | 7.60M | 88.95M | |||
| Other Financing Activity | -585.00K | -1.27M | 0.00 | 40.00M | 44.78M | |||
| FINANCING CASH FLOW | 106.13M | 49.66M | -25.21M | 14.60M | 133.73M | |||
| CHANGE IN CASH | 71.44M | 8.97M | -48.59M | -58.66M | -79.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -34.81M | -40.66M | -23.38M | -73.15M | -252.97M | |||
| Capital Expenditure | N/A | -33.00K | 0.00 | -110.00K | -60.00K | |||
| FREE CASH FLOW | -34.87M | -40.69M | -23.38M | -73.26M | -253.03M | |||
All data in USD